These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 24437521)

  • 1. Molecular interactions between mecamylamine enantiomers and the transmembrane domain of the human α4β2 nicotinic receptor.
    Bondarenko V; Targowska-Duda KM; Jozwiak K; Tang P; Arias HR
    Biochemistry; 2014 Feb; 53(5):908-18. PubMed ID: 24437521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LY2087101 and dFBr share transmembrane binding sites in the (α4)3(β2)2 Nicotinic Acetylcholine Receptor.
    Deba F; Ali HI; Tairu A; Ramos K; Ali J; Hamouda AK
    Sci Rep; 2018 Jan; 8(1):1249. PubMed ID: 29352227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of an intrasubunit nicotinic acetylcholine receptor-binding site for the positive allosteric modulator Br-PBTC.
    Norleans J; Wang J; Kuryatov A; Leffler A; Doebelin C; Kamenecka TM; Lindstrom J
    J Biol Chem; 2019 Aug; 294(32):12132-12145. PubMed ID: 31221718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human alpha4beta2 acetylcholine receptors formed from linked subunits.
    Zhou Y; Nelson ME; Kuryatov A; Choi C; Cooper J; Lindstrom J
    J Neurosci; 2003 Oct; 23(27):9004-15. PubMed ID: 14534234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Engineered α4β2 nicotinic acetylcholine receptors as models for measuring agonist binding and effect at the orthosteric low-affinity α4-α4 interface.
    Ahring PK; Olsen JA; Nielsen EØ; Peters D; Pedersen MH; Rohde LA; Kastrup JS; Shahsavar A; Indurthi DC; Chebib M; Gajhede M; Balle T
    Neuropharmacology; 2015 May; 92():135-45. PubMed ID: 25595102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tricyclic antidepressants and mecamylamine bind to different sites in the human alpha4beta2 nicotinic receptor ion channel.
    Arias HR; Rosenberg A; Targowska-Duda KM; Feuerbach D; Jozwiak K; Moaddel R; Wainer IW
    Int J Biochem Cell Biol; 2010 Jun; 42(6):1007-18. PubMed ID: 20223294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The unique α4+/-α4 agonist binding site in (α4)3(β2)2 subtype nicotinic acetylcholine receptors permits differential agonist desensitization pharmacology versus the (α4)2(β2)3 subtype.
    Eaton JB; Lucero LM; Stratton H; Chang Y; Cooper JF; Lindstrom JM; Lukas RJ; Whiteaker P
    J Pharmacol Exp Ther; 2014 Jan; 348(1):46-58. PubMed ID: 24190916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-agonist-binding subunit interfaces confer distinct functional signatures to the alternate stoichiometries of the alpha4beta2 nicotinic receptor: an alpha4-alpha4 interface is required for Zn2+ potentiation.
    Moroni M; Vijayan R; Carbone A; Zwart R; Biggin PC; Bermudez I
    J Neurosci; 2008 Jul; 28(27):6884-94. PubMed ID: 18596163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bupropion and its photoreactive analog (±)-SADU-3-72 interact with luminal and non-luminal sites at human α4β2 nicotinic acetylcholine receptors.
    Arias HR; Feuerbach D; Ortells MO
    Neurochem Int; 2016 Nov; 100():67-77. PubMed ID: 27612850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential α4(+)/(-)β2 Agonist-binding Site Contributions to α4β2 Nicotinic Acetylcholine Receptor Function within and between Isoforms.
    Lucero LM; Weltzin MM; Eaton JB; Cooper JF; Lindstrom JM; Lukas RJ; Whiteaker P
    J Biol Chem; 2016 Jan; 291(5):2444-59. PubMed ID: 26644472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potentiation of a neuronal nicotinic receptor via pseudo-agonist site.
    Mazzaferro S; Bermudez I; Sine SM
    Cell Mol Life Sci; 2019 Mar; 76(6):1151-1167. PubMed ID: 30600358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anesthetic effects on the structure and dynamics of the second transmembrane domains of nAChR alpha4beta2.
    Cui T; Canlas CG; Xu Y; Tang P
    Biochim Biophys Acta; 2010 Feb; 1798(2):161-6. PubMed ID: 19715664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unorthodox Acetylcholine Binding Sites Formed by α5 and β3 Accessory Subunits in α4β2* Nicotinic Acetylcholine Receptors.
    Jain A; Kuryatov A; Wang J; Kamenecka TM; Lindstrom J
    J Biol Chem; 2016 Nov; 291(45):23452-23463. PubMed ID: 27645992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unraveling amino acid residues critical for allosteric potentiation of (α4)3(β2)2-type nicotinic acetylcholine receptor responses.
    Wang ZJ; Deba F; Mohamed TS; Chiara DC; Ramos K; Hamouda AK
    J Biol Chem; 2017 Jun; 292(24):9988-10001. PubMed ID: 28446611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Roles of accessory subunits in alpha4beta2(*) nicotinic receptors.
    Kuryatov A; Onksen J; Lindstrom J
    Mol Pharmacol; 2008 Jul; 74(1):132-43. PubMed ID: 18381563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An Accessory Agonist Binding Site Promotes Activation of α4β2* Nicotinic Acetylcholine Receptors.
    Wang J; Kuryatov A; Sriram A; Jin Z; Kamenecka TM; Kenny PJ; Lindstrom J
    J Biol Chem; 2015 May; 290(22):13907-18. PubMed ID: 25869137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo chronic nicotine exposure differentially and reversibly affects upregulation and stoichiometry of α4β2 nicotinic receptors in cortex and thalamus.
    Fasoli F; Moretti M; Zoli M; Pistillo F; Crespi A; Clementi F; Mc Clure-Begley T; Marks MJ; Gotti C
    Neuropharmacology; 2016 Sep; 108():324-31. PubMed ID: 27157710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective potentiation of (α4)3(β2)2 nicotinic acetylcholine receptors augments amplitudes of prefrontal acetylcholine- and nicotine-evoked glutamatergic transients in rats.
    Grupe M; Paolone G; Jensen AA; Sandager-Nielsen K; Sarter M; Grunnet M
    Biochem Pharmacol; 2013 Nov; 86(10):1487-96. PubMed ID: 24051136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drimane Sesquiterpenoids Noncompetitively Inhibit Human α4β2 Nicotinic Acetylcholine Receptors with Higher Potency Compared to Human α3β4 and α7 Subtypes.
    Arias HR; Feuerbach D; Schmidt B; Heydenreich M; Paz C; Ortells MO
    J Nat Prod; 2018 Apr; 81(4):811-817. PubMed ID: 29634269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Photolabeling a Nicotinic Acetylcholine Receptor (nAChR) with an (α4)3(β2)2 nAChR-Selective Positive Allosteric Modulator.
    Hamouda AK; Deba F; Wang ZJ; Cohen JB
    Mol Pharmacol; 2016 May; 89(5):575-84. PubMed ID: 26976945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.